SB 562

Maryland Senate bill in Session 2026.

Status: enacted. Latest action: June 15, 2026.

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders.

Bill ID MD-2026-SB-562

Session 2026

Status enacted

Committee Finance; Health

Senate enacted 2026-06-15

Drug / Cannabis Policy

Summary

Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

Sponsor

Senator Gile

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2026-02-04	Introduced	Bill introduced
2026-06-15	Status	enacted
2026-06-15	Latest Action	Approved by the Governor - Chapter 54

More Bills From This Sponsor

SB 563

Health Facilities - Confidentiality of Medical Records - Crisis Pregnancy Clinics

introduced • Senate

SB 564

State Government - Office of the Attorney General - Data Protection

passed_upper • Senate

SB 88

State Board of Examiners for Audiologists, Hearing Aid Dispensers, Speech-Language Pathologists, and Music Therapists - Authority to Issue Limited Licenses to Practice Music Therapy

enacted • Senate

SB 890

Insurance - Captive Insurers - Premium Receipts Tax Study

enacted • Senate

SB 891

Health, Health Insurance, and Health Occupations - Perinatal Behavioral Health Conditions

enacted • Senate

SB 892

Health Occupations, Public Health, and Insurance - Menopause - Provider Training Coverage Requirements, Policy Initiatives, and Access to Care

enacted • Senate